Aytekin Akyol

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Özge Saatci, Aysegül Kaymak, Umar Raza et al. · Nature Communications · 2020 · 364 citations · Full text

Medicine, Cancer Biology, Oncology +17

Mouse Model of Colonic Adenoma-Carcinoma Progression Based on Somatic <i>Apc</i> Inactivation

Takao Hinoi, Aytekin Akyol, Brian Theisen et al. · Cancer Research · 2007 · 323 citations

Medicine, Molecular Genetics, Oncology +17

Mouse Model of Human Ovarian Endometrioid Adenocarcinoma Based on Somatic Defects in the Wnt/β-Catenin and PI3K/Pten Signaling Pathways

Rong Wu, Neali Hendrix-Lucas, Rork Kuick et al. · Cancer Cell · 2007 · 312 citations · Full text

Medicine, Cancer Biology, Oncology +16

Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer

Özge Saatci, Simone Borgoni, Özge Akbulut et al. · Oncogene · 2018 · 81 citations · Full text

Medicine, Cell Biology, Oncology +15

Maternal <i>Cdx2</i> is dispensable for mouse development

Stephanie Blij, Tristan Frum, Aytekin Akyol et al. · Development · 2012 · 57 citations · Full text

Life Sciences, Developmental Biology, Genetics +13